Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the / ratio

Author： Nahum A.E. Movsas B. Horwitz E.M. Stobbe C.C. Chapman J.D.

Publisher： Elsevier

ISSN： 0360-3016

Source： International Journal of Radiation Oncology*Biology*Physics, Vol.57, Iss.2, 2003-10, pp. : 391-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Prostate Tumor Xenografts as Representative Models for Clinical Prostate Cancer

By van Weerden W.M. van Steenbrugge G.J.

Urologic Oncology: Seminars and Original Investigations, Vol. 2, Iss. 4, 1996-07 ,pp. : 122-125

Elsevier

Access to resources Recommend Favorite

Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies

By Chan Norman Milosevic Michael Bristow Robert G

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 329-341

Future Medicine

Access to resources Recommend Favorite

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer

By Nordsmark Marianne Overgaard Jens

Acta Oncologica, Vol. 43, Iss. 4, 2004-06 ,pp. : 396-403

Informa Healthcare

Access to resources Recommend Favorite

Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X. Alcover J. Molina R. Rodriguez A. Carretero P. Ballesta A.M.

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite

Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer

By Sharifi Nima

Future Oncology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1239-1241

Future Medicine

Access to resources Recommend Favorite